DYLAN KUON: Open Payments
NPI 1851856389 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 28 payments from 9 companies in 2025. Trend: 2023 $1,312 · 2024 $671 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $138 |
| Sumitomo Pharma America, Inc. | 7 | $129 |
| Olympus America Inc. | 5 | $85 |
| UROGEN PHARMA, INC. | 2 | $67 |
| Dendreon Pharmaceuticals LLC | 3 | $61 |
| Laborie Medical Technologies Corp. | 1 | $53 |
| Janssen Biotech, Inc. | 1 | $23 |
| Endo USA, Inc. | 1 | $17 |
| COLOPLAST CORP | 1 | $16 |
Products named: GEMTESA, BOTOX, iTIND System, JELMYTO, PROVENGE, ERLEADA, XIAFLEX, LUPRON DEPOT.
Industry payments across LA — which companies pay providers there.
